Rhenman & Partners Asset Management AB Increases Position in

Rhenman & Partners Asset Management AB grew its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 105.3% during the fourth quarter, HoldingsChannel reports. The firm owned 390,000 shares of the company’s stock after acquiring an additional 200,000 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Relay Therapeutics were worth […]

Related Keywords

Leerink Partnrs , Stifel Nicolaus , Barclays , Hightower Advisors , Relay Therapeutics Inc , Nasdaq , Norges Bank , Charles Schwab Investment Management Inc , Partners Asset Management , Relay Therapeutics , Free Report , Tower Advisors , Charles Schwab Investment Management , Schwab Investment Management , Get Free Report , Visit Holdingschannel , Relay Therapeutics Daily ,